Analysis of HCC70 breast cancer cells incubated with SAT and NIC showed significant increase in gene expression of Cd137 (hCd137: 2.1 ± 1.0-fold, p ≤ 0.05; mCd137: 8.6 ± 0.6-fold, p ≤ 0.01), Tmem26 (hTmem26: 4.2 ± 0.7-fold, p ≤ 0.01; mTmem26:4.3 ± 0.8-fold, p ≤ 0.01), Il13 (hIl13: 3.6 ± 0.5-fold, p ≤ 0.01; mIl13: 2.2 ± 0.3-fold, p ≤ 0.05), Il10 (hIl10: 2.6 ± 0.5-fold, p ≤ 0.05; mIl10: 1.8 ± 0.2-fold, p ≤ 0.05), Il4 (hIl4: 2.1 ± 0.1-fold, p ≤ 0.05), and Cd163 (hCd163: 4.8 ± 0.8-fold, p ≤ 0.01; mCd163: 3.6 ± 0.7-fold, p ≤ 0.05) (Figure 4(d)). This evidence concerns the gene CD163 and breast cancer.